Forte Biosciences Inc. (FBRX)

Name: Forte Biosciences Inc. (FBRX) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Forte Biosciences Inc. (FBRX)

Stock Card

$76.99

$0.00 (0.00%)

As on 28-Aug-2026 09:30EDT

Market cap

$1,634 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

8.9

Div. Yield

0 %

Forte Biosciences (FBRX) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 76.99 High: 76.99

52 Week Range

Low: 10.11 High: 77.19

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.6 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

1.9
Debt to Equity

0
Book Value

$--
EPS

$-4.6
Face value

--
Shares outstanding

21,229,087

9 Years Aggregate

CFO

$-190.94 Mln

EBITDA

$-199.94 Mln

Net Profit

$-294.07 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Forte Biosciences (FBRX)	182.3	0.6	258.6	589.9	54.2	-35.8	--
BSE Sensex^*	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | *As on 04-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Forte Biosciences (FBRX)	20.1	10.4	-17.8	-53.3	-94.1	355.2	-93.5
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Forte Biosciences (FBRX)	77.0	1,634.4	0.0	-87.9	--	-71.8	--	8.9
Arrowhead Pharmaceuticals (ARWR)	84.8	11,993.9	669.5	-320.0	-0.8	-71.1	--	26.9
Ascendis Pharma A/S - ADR	268.4	16,261.1	1,054.4	755.9	5.7	--	19	9.8
Cytokinetics Inc (CYTK)	72.4	10,022.2	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	59.0	13,491.7	2,435.9	860.6	31.0	43	17.4	7.4
Halozyme Therapeutics (HALO)	110.2	11,957.0	1,663.7	413.6	36.3	430	30.9	84.5
Krystal Biotech (KRYS)	355.5	10,402.8	440.5	241.5	33.4	18.7	44.1	7.8
Kymera Therapeutics (KYMR)	118.2	9,718.7	105.0	-299.7	-227.2	-19.4	--	6.6
Madrigal Pharmaceuticals (MDGL)	541.4	12,332.1	1,283.9	-325.1	-19.0	-57.7	--	24.0
Medpace Holdings (MEDP)	592.0	16,765.1	2,782.3	491.5	21.1	110.1	35.2	39.3

Shareholding Pattern

View Details

About Forte Biosciences (FBRX)

Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a proprietary molecule with applications... for celiac disease, vitiligo, and alopecia areata; and services, including the clinical development and management of its Phase 2 clinical trials. Forte Biosciences, Inc. was incorporated in 2007 and is based in Dallas, Texas. As of August 27, 2026, Forte Biosciences, Inc. operates as a subsidiary of argenx SE. Read more

CEO, President & Chairman

Dr. Paul A. Wagner Ph.D.
CEO, President & Chairman

Dr. Paul A. Wagner Ph.D.
Headquarters

Dallas, TX
Website

https://www.fortebiorx.com

FAQs for Forte Biosciences (FBRX)

What is the current share price of Forte Biosciences Inc (FBRX) Today?

The share price of Forte Biosciences Inc (FBRX) is $76.99 (NASDAQ) as of 28-Aug-2026 09:30 EDT. Forte Biosciences Inc (FBRX) has given a return of 54.2% in the last 3 years.

What is the current PB & PE ratio of Forte Biosciences Inc (FBRX)?

Since, TTM earnings of Forte Biosciences Inc (FBRX) is negative, P/E ratio is not available.
The P/B ratio of Forte Biosciences Inc (FBRX) is 8.89 times as on 27-Aug-2026, a 72 premium to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-7.02	7.99
2024	-4.09	2.77
2023	-0.95	0.85
2022	-0.06	0.02
2021	-0.06	0.03

What is the 52 Week High and Low of Forte Biosciences Inc (FBRX)?

The 52-week high and low of Forte Biosciences Inc (FBRX) are Rs 77.19 and Rs 10.11 as of 05-Sep-2026.

What is the market cap of Forte Biosciences Inc (FBRX)?

Forte Biosciences Inc (FBRX) has a market capitalisation of $ 1,634 Mln as on 27-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Forte Biosciences Inc (FBRX)?

Before investing in Forte Biosciences Inc (FBRX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.